These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 19007972

  • 41. Genital papillomavirus in Greek women with high-grade cervical intraepithelial neoplasia and cervical carcinoma.
    Labropoulou V, Diakomanolis E, Dailianas S, Kalpaktsoglou K, Rodolakis A, Beaudenon S, Kakkanas A, Mavromara P.
    J Med Virol; 1996 Jan; 48(1):80-7. PubMed ID: 8825715
    [Abstract] [Full Text] [Related]

  • 42. [Detection and genetic typing of human papillomaviruses in cervical biopsies in Cagliari Province].
    Laconi S, Greco M, Pellegrini-Bettoli P, Pani P, Laconi E, Rais M.
    Pathologica; 2000 Aug; 92(4):236-40. PubMed ID: 11029883
    [Abstract] [Full Text] [Related]

  • 43. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
    Syrjänen K, Shabalova I, Sarian L, Naud P, Longatto-Filho A, Derchain S, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Serpa Hammes L, Podistov J, Costa S, Syrjänen S, NIS Study Research Group, LAMS Study Research Group.
    Eur J Gynaecol Oncol; 2012 Aug; 33(1):5-14. PubMed ID: 22439398
    [Abstract] [Full Text] [Related]

  • 44. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
    Li Y, Zeng WJ, Ye F, Wang XY, Lü WG, Ma D, Wei LH, Xie X.
    Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
    [Abstract] [Full Text] [Related]

  • 45. Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.
    Syrjänen K, Shabalova I, Naud P, Derchain S, Sarian L, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Hammes LS, Costa S, Podistov J, Syrjänen S, NIS and the LAMS Study Research Groups, Analysis of the combined prospective cohort of the NIS, LAMS Studies.
    Int J STD AIDS; 2011 May; 22(5):263-72. PubMed ID: 21571974
    [Abstract] [Full Text] [Related]

  • 46. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
    Tian R, Cui Z, He D, Tian X, Gao Q, Ma X, Yang JR, Wu J, Das BC, Severinov K, Hitzeroth II, Debata PR, Xu W, Zhong H, Fan W, Chen Y, Jin Z, Cao C, Yu M, Xie W, Huang Z, Bao Y, Xie H, Yao S, Hu Z.
    Carcinogenesis; 2019 Oct 16; 40(10):1220-1228. PubMed ID: 31102403
    [Abstract] [Full Text] [Related]

  • 47. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Hammes LS, Branca M, Grunjberga V, Erzen M, Sarian LO, Juschenko A, Costa S, Podistov J, Syrjänen S, New Independent States of the Former Soviet Union and the Latin American Screening Study Research Groups.
    Int J Gynecol Cancer; 2009 Jul 16; 19(5):934-42. PubMed ID: 19574788
    [Abstract] [Full Text] [Related]

  • 48. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.
    Sheng Z, Minato H, Sasagawa T, Nakada S, Kinoshita E, Kurose N, Nojima T, Makinoda S.
    Int J Clin Exp Pathol; 2013 Jul 16; 6(10):2168-77. PubMed ID: 24133595
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D, Zhang L, Xie F, Peng D, Wei J, Jiang L, Zhang S, Qi D.
    BMC Cancer; 2020 Aug 26; 20(1):810. PubMed ID: 32847541
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Usefulness of PCR in situ hybridization as a technique for morphological detection of human papillomavirus in uterine cervical neoplasia.
    Oguchi T, Sato S, Xiao YH, Yokoyama Y, Saito Y.
    Eur J Gynaecol Oncol; 2000 Aug 26; 21(6):585-7. PubMed ID: 11214615
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.
    Hui C, Bai H, Liu J, Lu X, Wang S, Zhang Z, Jin M, Wang Y, Liu Y.
    Diagn Pathol; 2021 Feb 19; 16(1):13. PubMed ID: 33608003
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential.
    Ding DC, Hsu HC, Huang RL, Lai HC, Lin CY, Yu MH, Chu TY.
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct 19; 140(2):245-51. PubMed ID: 18502563
    [Abstract] [Full Text] [Related]

  • 60. Human papillomavirus investigation of patients with cervical intraepithelial neoplasia 3, some of whom progressed to invasive cancer.
    Shah KV, Kessis TD, Shah F, Gupta JW, Shibata D, Jones RW.
    Int J Gynecol Pathol; 1996 Apr 19; 15(2):127-30. PubMed ID: 8786201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.